BLK and obesity due to melanocortin 4 receptor deficiency: BLK (rs1478898-A) was also found to be associated with decreased risk of obesity (OR = 0.97, P = 5.6×10−8) and type 2 diabetes (OR = 0.96, P = 4.5 × 10−5).